|
Volumn , Issue 2, 2005, Pages
|
Single agent versus combination chemotherapy for metastatic breast cancer.
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BREAST TUMOR;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DISEASE COURSE;
FEMALE;
HUMAN;
META ANALYSIS;
MORTALITY;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
DISEASE PROGRESSION;
FEMALE;
HUMANS;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIALS;
TREATMENT OUTCOME;
|
EID: 21844462141
PISSN: None
EISSN: 1469493X
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (84)
|
References (64)
|